OH-PROCTER-&-GAMBLE
14.9.2021 18:31:10 CEST | Business Wire | Press release
Procter & Gamble (NYSE:PG) is announcing a comprehensive plan to accelerate action related to climate change. P&G has also set a new ambition to achieve net zero greenhouse gas (GHG) emissions across its operations and supply chain, from raw material to retailer, by 2040 as well as interim 2030 goals to make meaningful progress this decade.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210914005927/en/
The climate crisis affects every home and family, everywhere in the world. The majority of consumers globally now want brands they buy to help them live a more environmentally conscious lifestyle and the latest science has made it clear that urgent, decisive action must be taken to avoid the worst impacts of climate change.
“We are fully committed to use P&G’s innovation and ingenuity to unlock new solutions to address climate change,” said David S. Taylor, Chairman, P&G President and Chief Executive Officer. “The task ahead of us is urgent, difficult and much bigger than any single company or country. P&G is tackling these challenges head-on by reducing our footprint and leveraging our scale to foster unprecedented collaboration across our value chain.”
P&G’s actions on climate began over a decade ago, and we know there is more work to do. Our science-based plan to net zero will prioritize cutting most of our emissions across our operations and supply chain, from raw material to retailer. For residual emissions in these categories that cannot be eliminated, we will use natural or technical solutions that remove and store carbon.
Our 2030 goals to pace our progress toward net zero were submitted to The Science Based Targets initiative (SBTi) :
- Reducing emissions across our operations by 50%
- Reducing emissions across our supply chain by 40%1
We have joined the UN’s Race to Zero and the Business Ambition for 1.5°C campaigns and are also sharing our new Climate Transition Action Plan , which outlines a comprehensive approach to accelerating climate action and the key challenges ahead. More perspective is available here . We will continue to communicate our successes and setbacks along the way so others can learn with us and advance collective progress.
“While no one has all of the answers on how to bring a net zero future into focus, we will not let uncertainty hold us back,” said Virginie Helias, P&G Chief Sustainability Officer. “To achieve these goals, we will leverage existing solutions and seek transformative new ones that are not available in the marketplace today. This will require partnership across the private, nonprofit, and public sectors and involve every aspect of our business, from the very beginning of our products’ lifecycle to the very end.”
Acting with Urgency to Reduce Emissions
Our top priority is to significantly reduce GHG emissions as quickly as possible with solutions that exist today.
- Reducing emissions across our operations. From 2010 to 2020 we have reduced absolute emissions across our global operations 52% through energy efficiency and renewable electricity. As we continue to reduce emissions, we are also advancing natural climate solutions to balance any remaining emissions from our operations that cannot be eliminated by 2030. These include new projects that help protect and restore forests and other ecosystems essential to the people and wildlife that call them home.
- Accelerating renewable electricity. We are nearing our 2030 goal of purchasing 100% renewable electricity by already purchasing 97% globally. In 2021, the United States Environmental Protection Agency recognized P&G as #5 on its National Top 100 list of green power users and #2 on its Top 30 list for on-site renewable power generation nationwide, making us top-rated in the consumer products industry.
- Decarbonizing our supply chain and logistics. Our supply chain and logistics emissions from raw material to retailer are about 10 times that of our operations and we have set a goal to reduce emissions 40%1 by 2030. We are also planning to increase transportation efficiency of outbound finished products 50% by 2030. Pampers is actively working with suppliers to reduce their carbon footprint and avoided an estimated one million metric tons of GHG from the production of its materials over the past five years. P&G established a new Product Supply Innovation Center (PSIC) in Kronberg, Germany as a hub for a network of local suppliers, tech companies, and top universities, developing solutions that are global and scalable to help decarbonize our supply chain.
Tackling Challenges by Inventing New Solutions
We know there are some operational emissions we cannot eliminate yet and our teams are working hard to develop the next generation of low-carbon technologies and materials. Our efforts in this area include:
- Leveraging renewable thermal energy. We use geothermal, solar, and renewable steam at some manufacturing sites, but continuing to reduce emissions will require more innovation. We have partnered with the World Wildlife Fund, manufacturers, and local governments to create the Renewable Thermal Collaborative to identify and scale renewable, cost-competitive thermal energy solutions. “Thermal energy represents a significant challenge for many industries as they chart a path towards net zero,” said Marcene Mitchell, Senior Vice President, Climate Change, World Wildlife Fund. “The Renewable Thermal Collaborative can help unlock sustainable, scalable solutions that cut emissions. P&G is a founding member of the RTC and has shown strong leadership in this space.”
- Advancing low-carbon technologies, materials, and packaging. To unlock new ways to decarbonize our supply chain, we are partnering to advance innovation in materials derived from renewable, bio-based, or recycled carbon across brands including Head & Shoulders, Pantene, Ariel, Tide and Pampers.
- Exploring Ingredients made from captured CO2 . Our Tide brand is working with Twelve, a Silicon Valley start-up, to explore their carbon capture technology to incorporate CO2 from emissions into ingredients that could be used across Tide.
Creating a Decarbonized Future Through Transformative Collaboration
We are going beyond our net zero ambition and doing more to make a collective impact - partnering with consumers to reduce GHG emissions from the use phase of products, creating alliances for carbon-efficient homes, and advocating for policy solutions to decarbonize energy infrastructure. Our efforts here include:
- Making sustainability effortless at home. P&G and its brands will continue to provide consumers with tools and information on how small actions at home can make a world of difference for the planet .
- Reducing 15 million tons of carbon through cold water washing, and accelerating impact with an additional 30 million tons by 2030. We have leveraged innovation and sustained consumer education to help reduce the largest portion of our carbon footprint – the energy needed to heat water during product use. P&G brands Tide and Ariel have helped consumers increase their use of low-energy laundry cycles to avoid roughly 15 million metric tons of carbon dioxide. Tide and Ariel continue to drive greater use of cold water washing through new education campaigns to help avoid an additional 30 million tons of carbon emissions by 2030 – more than ten times that of P&G’s yearly global operations.
- Creating the home of the future. We are advancing solutions to make everyday living more sustainable, with industry partners via the 50L Home Coalition . By helping people reduce hot water use without trade-offs, the Coalition is creating more efficient homes that can use 10 times less water than most use today.
“Caring for our consumers and our planet is core to all of us at P&G,” Taylor added. “There is no action too small, and no vision too big, as we all work together to preserve our shared home for generations to come.”
For more detailed information about P&G’s commitments and progress, please see P&G’s Climate Transition Action Plan and blog . To learn more about P&G’s ESG efforts, visit the ESG website or read the 2020 Citizenship Report .
About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at www.pg.com/news .
Forward-Looking Statements
Certain statements in this release, including statements relating to our climate and related ESG targets, estimates, projections, goals, commitments, and expected results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words “believe” “project” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” “goal," “target,” “objective,” and similar expressions. Forward-looking statements speak only as of the date they are made and are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results and outcomes to differ materially from those expressed or implied in the forward-looking statements. Some of these uncertainties are summarized in the section of our Climate Transition Action Plan titled, “Sources of Uncertainty.” For additional information concerning factors that could cause actual results and events to differ materially from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events, or otherwise, except to the extent required by law.
1 Our Scope 3 2030 goals, submitted to SBTi, are as follows:
- Reducing supply chain emissions from priority categories by 40% per unit of production by 2030. P&G priority categories account for over 90% of P&G’s supply chain emissions.
- Reducing global upstream finished product freight emissions intensity by 50% by 2030.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210914005927/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Doubtless Pet Care Launches to Provide Peace of Mind to Pet Parents and Help Their Pets Live Happier, Healthier Lives29.6.2026 10:15:00 CEST | Press release
Doubtless combines industry-leading pet insurance with innovative care solutions, protecting more than 6 million pets across 10 global markets Doubtless launches today with the goal of helping more pet parents across the world access quality care for the pets they love. The company brings together a leading global portfolio of pet insurance brands with a growing range of connected solutions designed to support pet parents at every stage of their pet’s life. With over 4,000 employees, Doubtless insures 6 million pets across 10 markets in North America, Europe and the United Kingdom. “Uncertainty about the financial commitments associated with having a pet should never keep families from experiencing the joy of a life with pets,” said Dirk Beeckman, CEO of Doubtless. “By harnessing the power of our international footprint, we are building on our leadership in pet insurance to create a global suite of solutions for pet parents, veterinarians and industry partners that makes pet care easie
Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 09:19:00 CEST | Press release
Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24Phase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patie
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 09:00:00 CEST | Press release
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 09:00:00 CEST | Press release
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa More than one million people are living with Parkinson’s disease in the European Union, and over 80% experience motor fluctuations during the course of their disease, highlighting the need for additional treatment options Hopledo® contains a unique formulation combining immediate-release granules and extended-release pellets, providing both a rapid onset of action and a longer duration of effect, sustaining the levodopa therapeutic effect for a longer period of time If approved, Zambon expects to make Hopledo® progressively available to patients with Parkinson’s disease across Europe starting October 2026 Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European M
Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 08:30:00 CEST | Press release
Approval based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s Enhertu that demonstrated clinically meaningful responses across a broad range of tumors Enhertu now approved for six indications in the EU Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across thr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
